<?xml version="1.0" encoding="UTF-8"?>
<ref id="B173-viruses-12-00571">
 <label>173.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Anticoli</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Manfredi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Chiozzini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Arenaccio</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Olivetta</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ferrantelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Capocefalo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Falcone</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ruggieri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Federico</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens</article-title>
  <source>Biotechnol. J.</source>
  <year>2018</year>
  <volume>13</volume>
  <fpage>e1700443</fpage>
  <pub-id pub-id-type="doi">10.1002/biot.201700443</pub-id>
  <?supplied-pmid 29274250?>
  <pub-id pub-id-type="pmid">29274250</pub-id>
 </element-citation>
</ref>
